Liver transplantation for primary biliary cirrhosis

GC MacQuillan, James Neuberger

Research output: Contribution to journalReview article

45 Citations (Scopus)

Abstract

Liver transplantation is the accepted treatment for patients with end-stage liver disease or intractable symptoms secondary to primary biliary cirrhosis (PBC), and has proven survival benefit. Indications for transplantation are an unacceptable quality of life or anticipated death in less than 1 year. Although there are a number of prognostic models, serum bilirubin provides the simplest guide to transplantation timing. Those grafted for PBC are at greater risk of developing chronic rejection, and are less likely to be successfully weaned from immunosuppression than those grafted for other indications. Following transplantation, antimitochondrial antibodies persist and histological features of recurrent PBC may be seen in the allograft in up to 50% by 10 years; however, at least in the medium-term, this rarely causes clinical problems.
Original languageEnglish
Pages (from-to)941-956
Number of pages16
JournalClinics in Liver Disease
Volume7
Issue number4
DOIs
Publication statusPublished - 1 Nov 2003

Fingerprint

Dive into the research topics of 'Liver transplantation for primary biliary cirrhosis'. Together they form a unique fingerprint.

Cite this